Clinical Trials
- Diseases of the Cardiovascular SystemOCEAN(a) CCTA - A double blinded, randomized, placebo controlled, multi-center study evaluating the safety, tolerability and effect of olpasiran on coronary artery plaque burden assessed by coronary computed tomography angiography in participants with stable atherosclerotic cardiovascular disease and elevated lipoprotein(a).Not accepting volunteers